What is the latest PARKHOSPS stock price?
The latest stored price for PARKHOSPS is Rs 282.05 as of 2026-09-18.
gimli
PARKHOSPS stock AI analysis
PARKHOSPS Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
PARK MEDI WORLD LIMITED is a small-cap stock in Healthcare. This Gimli page shows the latest available PARKHOSPS price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹282.05
1W return
+0.45%
1M return
+1.88%
3M return
+10.50%
6M return
+40.23%
1Y return
n/a
Market cap
₹12,182.61 cr
PE
60.53
PB
5.79
ROE
+12.46%
ROCE
+20.17%
RSI
50.48
Turnover
₹30.22 cr
Why it can matter in screens
- Momentum: PARKHOSPS is below 50DMA, below 200DMA; RSI is 50.48.
- Returns: 1D +1.49%, 1W +0.45%, 1M +1.88%, 3M +10.50%, 1Y n/a.
- Trend levels: 52W high ₹305.00, 52W low ₹251.00, off high -7.52%.
- Liquidity: latest turnover is ₹30.22 cr; volume vs 20D is +1.84%.
- Valuation/profitability: PE 60.53, PB 5.79, ROE +12.46%, ROCE +20.17%.
- Growth: 3Y sales CAGR +10.27%, 3Y profit CAGR +5.52%.
Quick Answers
Is PARKHOSPS above its 50DMA and 200DMA?
PARKHOSPS is below 50DMA, below 200DMA. The latest 50DMA is 282.61 and the latest 200DMA is n/a.
What are PARKHOSPS PE, ROE and ROCE?
PARKHOSPS has PE 60.53, ROE +12.46%, and ROCE +20.17% in Gimli's latest available snapshot.
How has PARKHOSPS performed recently?
PARKHOSPS has returned +1.88% over 1 month, +10.50% over 3 months, and n/a over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 38.20 cr | 5.95 cr | 1.08 cr | 2.05 |
| 2026-03-31 | 460.41 cr | 134.87 cr | 70.86 cr | 1.64 |
| 2025-12-31 | 409.97 cr | 108.51 cr | 50.78 cr | 1.35 |
| 2025-09-30 | 418.23 cr | 120.77 cr | 78.53 cr | nan |
| 2025-06-30 | 398.85 cr | 111.80 cr | 57.98 cr | 1.34 |
| 2025-03-31 | 353.92 cr | 97.00 cr | 44.84 cr | 1.04 |
| 2024-12-31 | 348.13 cr | 97.56 cr | 45.59 cr | 1.06 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 1,679.36 cr | 475.93 cr | 258.12 cr | 6.87 |
| 2025-03-31 | 1,393.57 cr | 403.40 cr | 201.64 cr | 4.67 |
| 2024-03-31 | 1,229.06 cr | 338.27 cr | 153.49 cr | 3.55 |
| 2023-03-31 | 1,252.38 cr | 404.74 cr | 219.67 cr | 5.09 |
| 2022-03-31 | 124.79 cr | 35.49 cr | 8.35 cr | 0.53 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 2,813.15 cr | 236.85 cr | 364.19 cr | 2,104.30 cr |
| 2025-03-31 | 2,133.70 cr | 103.00 cr | 682.07 cr | 1,126.28 cr |
| 2024-03-31 | 1,912.10 cr | 76.63 cr | 686.71 cr | 935.51 cr |
| 2023-03-31 | 1,592.82 cr | 100.05 cr | 575.68 cr | 729.97 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 329.09 cr | 209.41 cr | n/a |
| 2025-03-31 | 215.38 cr | 70.27 cr | n/a |
| 2024-03-31 | 361.44 cr | 289.98 cr | n/a |
| 2023-03-31 | 195.03 cr | 96.60 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +82.89% | +0.82% | +8.95% | +5.66% | +7.33% | +0.00% |
| 2026-03-31 | +82.89% | +0.86% | +9.25% | +5.62% | +6.99% | +0.00% |
| 2025-12-31 | +82.89% | +1.28% | +8.78% | +5.17% | +7.05% | +0.00% |
| 2025-12-16 | +82.89% | +1.97% | +6.66% | +2.73% | +8.48% | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 440,829.82 cr | 36.388220 | +15.50% | +11.45% |
| DIVISLAB | DIVI S LABORATORIES LTD | 248,876.81 cr | 85.407280 | +18.37% | +53.39% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 163,807.57 cr | 75.106636 | +17.33% | +35.67% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 128,608.22 cr | 65.670049 | +21.03% | +13.94% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 116,723.14 cr | 26.011308 | +16.04% | +10.70% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 33.401961 | +10.25% | -11.64% |
| LAURUSLABS | LAURUS LABS LIMITED | 105,487.98 cr | 96.587446 | +21.77% | +111.64% |
| MAXHEALTH | MAX HEALTHCARE INS LTD | 102,122.47 cr | 70.799892 | +14.33% | -10.58% |
Try these prompts
- Analyze PARK MEDI WORLD with valuation, momentum and industry peers
- Compare PARKHOSPS with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare PARKHOSPS with other Healthcare stocks
Data snapshot: 2026-09-18. Not investment advice.